Alle Storys
Folgen
Keine Story von Marseille-Kliniken AG mehr verpassen.

Marseille-Kliniken AG

EANS-Voting Rights: Marseille-Kliniken AG
Release according to article 26, section 1 WpHG (Securities Trading Act) with the aim of Europe-wide distribution

--------------------------------------------------------------------------------
  Notification of voting rights transmitted by euro adhoc. The issuer is
  responsible for the content of this announcement.
--------------------------------------------------------------------------------
Announcement according to Article 21, Section 1 of the WpHG (share)


1. Dr. h.c. Carsten Maschmeyer, Germany, has informed us on 20 December 2011
according to sec. 21 para. 1 of the WpHG that his share of voting rights in
Marseille-Kliniken AG has exceed the thresholds of 3% and 5% on 16 December 2011
and has amounted to 5.33% on this day. This is equivalent to 776,478 voting
rights of the overall 14,580,000 voting rights in Marseille-Kliniken AG.
 
4.49% (654,478 voting rights) are attributed to Dr. h.c. Carsten Maschmeyer
pursuant to sec. 22 para. 1 sentence 1 no. 1 of the WpHG.

Attributed voting rights are held by the following companies controlled by him,
whose voting rights in Marseille-Kliniken AG amounts to 3% or more:

- Paladin Asset Management GmbH
- MM Vermögensverwaltungs- GmbH & Co. KG
- MM Geschäftsführungs GmbH


2. MM Geschäftsführungs GmbH, Hanover, Germany, has informed us on 20 December
2011 according to sec. 21 para. 1 of the WpHG that their share of voting rights
in Marseille-Kliniken AG has exceed the thresholds of 3% on 16 December 2011 and
has amounted to 4.49% on this day. This is equivalent to 654,478 voting rights
of the overall 14,580,000 voting rights in Marseille-Kliniken AG.
 
4.49% (654.478 voting rights) are attributed to MM Geschäftsführungs GmbH
pursuant to sec. 22 para. 1 sentence 1 no. 1 of the WpHG.

Attributed voting rights are held by the following companies, controlled by MM
Geschäftsführungs GmbH, whose voting rights in Marseille-Kliniken AG amounts to
3% or more:

- Paladin Asset Management GmbH
- MM Vermögensverwaltungs- GmbH & Co. KG


3. MM Vermögensverwaltungs- GmbH & Co. KG, Hanover Germany, has informed us on
20 December 2011 according to sec. 21 para. 1 of the WpHG that their share of
voting rights in Marseille-Kliniken AG has exceed the thresholds of 3% on 16
December 2011 and has amounted to 4.49% on that day. This is equivalent to
654,478 voting rights of the overall 14,580,000 voting rights in
Marseille-Kliniken AG. 

4.49% (654,478 voting rights) are attributed to MM Vermögensverwaltungs- GmbH &
Co. KG pursuant to sec. 22 para. 1 sentence 1 no. 1 of the WpHG.

Attributed voting rights are held by the following companies, controlled by MM
Vermögensverwaltungs- GmbH & Co. KG, whose voting rights in Marseille-Kliniken
AG amounts to 3% or more:

- Paladin Asset Management GmbH


4. Paladin Asset Management GmbH, Hanover, Germany, has informed us on 20
December 2011 according to sec. 21 para. 1 of the WpHG that their share of
voting rights in Marseille-Kliniken AG has exceed the thresholds of 3% on 16
December 2011 and has amounted to 4.49% on this day. This is equivalent to
654,478 voting rights of the overall 14,580,000 voting rights in
Marseille-Kliniken AG.

Further inquiry note:
Christian Hillermann
Hillermann Consulting
Investor Relations Marseille-Kliniken AG
Poststraße 14/16
20354 Hamburg
Tel.: 040 / 320 279-10
Fax: 040 / 320 279-114
www.marseille-kliniken.de

end of announcement                               euro adhoc 
--------------------------------------------------------------------------------


issuer:      Marseille-Kliniken AG
             Alte Jakobstraße 79/80
             D-10179 Berlin
phone:       +49 (0)30 246 32-400
FAX:         +49 (0)30 246 32-401
mail:         info@marseille-kliniken.de
WWW:         http://www.marseille-kliniken.de
sector:      Pharmaceuticals
ISIN:        DE0007783003
indexes:     CDAX, Classic All Share, Prime All Share
stockmarkets: regulated dealing/prime standard: Frankfurt, free trade: Berlin,
             Stuttgart, Düsseldorf, regulated dealing: Hamburg 
language:   English

Original-Content von: Marseille-Kliniken AG, übermittelt durch news aktuell

Weitere Storys: Marseille-Kliniken AG
Weitere Storys: Marseille-Kliniken AG